Ibraheem Anas, Abdullah Abdullah
Internal Medicine/Clinical Hematology, Al Karama Teaching Hospital, Baghdad, IRQ.
General Medicine, Frimley Health NHS Foundation Trust/Wexham Park Hospital, Slough, GBR.
Cureus. 2023 Dec 27;15(12):e51172. doi: 10.7759/cureus.51172. eCollection 2023 Dec.
Thyrotoxicosis is a clinical condition characterized by inappropriately elevated thyroid hormone levels in the bloodstream, leading to systemic effects on the body. In fact, the thyrotoxic state has tight regulatory control over the cardiovascular system through genomic and non-genomic mechanisms. This study highlights a rare presentation of thyrotoxic cardiomyopathy (TCM), which, to the best of our knowledge, is one of the very few case reports involving heart failure with preserved ejection fraction (HFpEF) and only atrial involvement, compared to the previous literature. A 37-year-old female presented to the outpatient clinic with abdominal distention and neglected signs and symptoms consistent with thyrotoxicosis for a year. Investigations revealed high N-terminal pro-b-type natriuretic peptide (NT-proBNP) levels of 1788 pg/mL. Cardiac MRI and trans-thoracic echocardiogram (TTE) revealed bilateral atrial dilatation, a left ventricular ejection fraction (LVEF) of 60%, and diastolic dysfunction. Additionally, severe free-flowing tricuspid and mitral valve regurgitation were observed, with no evidence of pericardial effusion or ventricular abnormalities. Therefore, a diagnosis of TCM was suspected and eventually confirmed by excluding other differential diagnoses. Besides a diffuse goiter on ultrasonography, the thyroid panel test revealed low thyroid-stimulating hormone (TSH) levels of <0.01 mIU/L, a free thyroxine T4 of >100 pmol/L, and positive anti-thyroid peroxidase (TPO) and TSH receptor antibodies. Accordingly, a team of endocrinologists, cardiologists, and internists managed the patient with anti-thyroid medications alongside symptomatic treatment. A few days later, she was discharged in good condition, and a follow-up visit was arranged with the endocrinology and cardiology clinics. It is crucial to maintain a high level of suspicion to detect and treat TCM promptly, and a multidisciplinary approach should ideally be employed. This is not only important for the prevention of but also reversing potentially life-threatening cardiovascular complications.
甲状腺毒症是一种临床病症,其特征为血液中甲状腺激素水平异常升高,从而对身体产生全身性影响。事实上,甲状腺毒症状态通过基因组和非基因组机制对心血管系统有着严格的调控。本研究突出了甲状腺毒症性心肌病(TCM)的一种罕见表现,据我们所知,与以往文献相比,这是极少数涉及射血分数保留的心力衰竭(HFpEF)且仅累及心房的病例报告之一。一名37岁女性因腹胀前来门诊就诊,一年来一直忽视与甲状腺毒症相符的体征和症状。检查发现N末端B型利钠肽原(NT-proBNP)水平高达1788 pg/mL。心脏磁共振成像(MRI)和经胸超声心动图(TTE)显示双侧心房扩大,左心室射血分数(LVEF)为60%,且存在舒张功能障碍。此外,观察到严重的三尖瓣和二尖瓣反流,无心包积液或心室异常迹象。因此,怀疑为TCM,最终通过排除其他鉴别诊断得以确诊。除超声检查发现弥漫性甲状腺肿外,甲状腺功能检查显示促甲状腺激素(TSH)水平<0.01 mIU/L,游离甲状腺素T4>100 pmol/L,抗甲状腺过氧化物酶(TPO)和TSH受体抗体呈阳性。据此,内分泌科医生、心脏病专家和内科医生组成的团队用抗甲状腺药物并结合对症治疗来管理该患者。几天后,她情况良好出院,并安排了内分泌科和心脏病科门诊的随访。保持高度怀疑对于及时发现和治疗TCM至关重要,理想情况下应采用多学科方法。这不仅对预防而且对逆转潜在的危及生命的心血管并发症都很重要。